Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TLRD
3451
DELISTED
Tailored Brands, Inc.
TLRD
| $371K | ﹤0.01% |
396,328
-291,086
| -42% | -$385K |
|
|
QUMU
3452
DELISTED
Qumu Corp.
QUMU
| $370K | ﹤0.01% |
103,106
+10,245
| +11% | +$23.4K |
|
3453
Nomura Holdings
NMR
$28.3B
| $369K | ﹤0.01% |
83,134
+5,622
| +7% | +$23.4K |
|
|
LEAF
3454
DELISTED
Leaf Group Ltd.
LEAF
| $369K | ﹤0.01% |
100,583
-95,294
| -49% | -$198K |
|
3455
Natural Health Trends
NHTC
$14.7M
| $367K | ﹤0.01% |
64,477
| – | – |
|
|
ACCS
3456
ACCESS Newswire
ACCS
$25.6M
| $364K | ﹤0.01% |
35,897
| – | – |
|
|
WINS
3457
DELISTED
Wins Finance Holdings Inc. Ordinary Shares (Cayman Islands)
WINS
| $364K | ﹤0.01% |
+9,202
| New | +$144K |
|
3458
Alto Ingredients
ALTO
$369M
| $361K | ﹤0.01% |
508,733
+111,609
| +28% | +$56.3K |
|
|
TEF
3459
DELISTED
Telefonica
TEF
| $360K | ﹤0.01% |
88,927
+56,871
| +177% | +$220K |
|
3460
SK Telecom
SKM
$12.1B
| $359K | ﹤0.01% |
11,290
-5,761
| -34% | -$178K |
|
3461
Biomerica
BMRA
$4.6M
| $358K | ﹤0.01% |
6,188
+21
| +0.3% | +$1.18K |
|
|
DMK
3462
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $357K | ﹤0.01% |
9,499
+488
| +5% | +$16.7K |
|
|
BLU
3463
DELISTED
BELLUS Health Inc.
BLU
| $357K | ﹤0.01% |
34,556
+13,529
| +64% | +$137K |
|
3464
Bridgford Foods
BRID
$57.6M
| $354K | ﹤0.01% |
21,436
+2,400
| +13% | +$41.7K |
|
3465
Medallion Financial
MFIN
$229M
| $352K | ﹤0.01% |
133,169
-132,155
| -50% | -$317K |
|
3466
Brookfield Infrastructure Partners
BIP
$19.2B
| $349K | ﹤0.01% |
12,741
+196
| +2% | +$5.23K |
|
|
TBHC
3467
DELISTED
The Brand House Collective
TBHC
| $349K | ﹤0.01% |
129,057
| – | – |
|
3468
First Majestic Silver
AG
$7.41B
| $348K | ﹤0.01% |
35,034
+7,050
| +25% | +$59.7K |
|
3469
Microbot Medical
MBOT
$116M
| $348K | ﹤0.01% |
50,504
| – | – |
|
|
HIL
3470
DELISTED
Hill International, Inc. Common Stock
HIL
| $346K | ﹤0.01% |
227,989
| – | – |
|
3471
MPLX
MPLX
$59.3B
| $344K | ﹤0.01% |
19,944
-265
| -1% | -$4.53K |
|
3472
Atossa Therapeutics
ATOS
$20.6M
| $341K | ﹤0.01% |
5,994
| – | – |
|
3473
Dorchester Minerals
DMLP
$1.33B
| $341K | ﹤0.01% |
26,737
-879
| -3% | -$10K |
|
|
OSB
3474
DELISTED
Norbord Inc.
OSB
| $340K | ﹤0.01% |
+13,431
| New | +$231K |
|
3475
IAMGOLD
IAG
$8.2B
| $338K | ﹤0.01% |
85,468
+5,867
| +7% | +$20.2K |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.